Patents Assigned to Regeneration Technology
  • Patent number: 12196490
    Abstract: A rotary kiln with a stirring function is provided, including a kiln head, a roller and a kiln tail. The roller is obliquely arranged on the kiln head and the kiln tail. The rotary kiln further includes a mounting shaft and stirring mechanisms. Linkage elements are arranged on an inner wall of the roller. The linkage elements are configured to drive the stirring mechanisms to perform a stirring operation. Each of the stirring mechanisms includes a rotating ring sleeve and two limiting slide bases. The rotating ring sleeve is provided with three telescopic frame bodies. A telescopic baffle is arranged in each of the three telescopic frame bodies. A secondary propulsion assembly is arranged in a mounting groove. A sealing cover is arranged at an inner end of the telescopic baffle. The telescopic frame body is communicated with the rotating ring sleeve.
    Type: Grant
    Filed: August 1, 2022
    Date of Patent: January 14, 2025
    Assignees: CHANGZHOU INSTITUTE OF TECHNOLOGY, Gaoyou Huanchuang Resources Regeneration Technology Co., Ltd.
    Inventors: Pin Zhou, Yu Zhao, Jie Li, Changjin Zhu, Haiming Yang
  • Patent number: 11903894
    Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: February 20, 2024
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney
  • Patent number: 11844739
    Abstract: A handheld acoustic shock wave or pressure pulse applicator device has a body structure and an applicator head. The body structure has a proximal end and a distal end with a longitudinal axis extending between the ends. The applicator head is at the distal end. the head emits pressure pulses or shock waves at an inclined angle relative to the longitudinal axis of the body structure. The applicator head has a balloon or lens or membrane through which the emitted pressure pulses or shock waves pass. The lens or membrane is configured to be coupled directly or indirectly to an exposed soft tissue surface of a palate inside a patient's mouth to direct emitted pressure pulses or shock waves to the brain. The applicator device can be configured with the inclined obtuse angle fixed between 150 degrees and 90 degrees or can be adjustable between 180 degrees and 90 degrees.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: December 19, 2023
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventor: John F. Warlick
  • Patent number: 11839394
    Abstract: The present invention relates to a reflector for an acoustic shock or pressure wave head, wherein the reflector comprises an acoustically reflective surface formed by a body of rotation, said body of rotation being formed by rotation of an elliptical segment about a rotation axis which extends through a focal point of the ellipse and encloses an angle ? between 0.1° and 30° with the main axis of the ellipse.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: December 12, 2023
    Assignees: Medizinische Universität Innsbruck, Heart Regeneration Technologies GMBH
    Inventors: Christian Dorfmüller, Johannes Holfeld, Michael Grimm
  • Patent number: 11826301
    Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a gland, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the gland to acoustic shock waves stimulating the gland to have a modulated response. The modulated response is one of an adjustment in hormonal release which increases low level output, decreases high level output or stabilizes erratic output. The emitted acoustic shock waves are focused or unfocused low energy acoustic shock waves. The gland underlies the patient's skin. The shock wave generator is acoustically coupled to the patient's skin using a coupling gel or liquid. The gland is one of a testicle, ovary, pituitary gland, adrenal gland, thyroid gland, thymus, pineal gland, parathyroid, or hypothalamus. The method can be repeated one or more times.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: November 28, 2023
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventor: John F. Warlick
  • Patent number: 11771620
    Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: October 3, 2023
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney
  • Patent number: 11771621
    Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: October 3, 2023
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney
  • Publication number: 20230029864
    Abstract: A rotary kiln with a stirring function is provided, including a kiln head, a roller and a kiln tail. The roller is obliquely arranged on the kiln head and the kiln tail. The rotary kiln further includes a mounting shaft and stirring mechanisms. Linkage elements are arranged on an inner wall of the roller. The linkage elements are configured to drive the stirring mechanisms to perform a stirring operation. Each of the stirring mechanisms includes a rotating ring sleeve and two limiting slide bases. The rotating ring sleeve is provided with three telescopic frame bodies. A telescopic baffle is arranged in each of the three telescopic frame bodies. A secondary propulsion assembly is arranged in a mounting groove. A sealing cover is arranged at an inner end of the telescopic baffle. The telescopic frame body is communicated with the rotating ring sleeve.
    Type: Application
    Filed: August 1, 2022
    Publication date: February 2, 2023
    Applicants: CHANGZHOU INSTITUTE OF TECHNOLOGY, Gaoyou Huanchuang Resources Regeneration Technology Co., Ltd.
    Inventors: Pin Zhou, Yu Zhao, Jie Li, Changjin Zhu, Haiming Yang
  • Patent number: 11458069
    Abstract: A treatment method to reduce or eliminate a patient's symptoms caused by a medical condition or disease is disclosed. The treatment has the step of administering acoustic shock waves directed to one or more reflexology zones or to one or more reflexology zones and an area near a source of the pain if any is exhibited to treat the medical condition. The treatment further has the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the one or more reflexology zones or the one or more reflexology zones and the area near a source of the medical condition or pain, if any is exhibited, to acoustic shock waves to treat the medical condition.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: October 4, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney
  • Patent number: 11389372
    Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a reflexology zone has been discovered. In one preferred embodiment, a treatment method achieves one or more of a) modulating blood sugar levels, b) stimulating insulin production levels or c) normalizing A1C levels by administering acoustic shock waves to a reflexology zone or region of a patient. The treatment method further has the steps of: activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves; subjecting the reflexology zone to acoustic shock waves stimulating the pancreas to have a modulated response wherein the modulated response is one of an adjustment in blood sugar levels or insulin production and release or normalizing A1C levels which increases low level output, decreases high level output or stabilizes erratic output; and wherein the emitted acoustic shock waves are focused or unfocused.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: July 19, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney, Janey Lynn Watts
  • Patent number: 11389370
    Abstract: A method of treating red blood cells of a human patient has the steps of activating an acoustic shock wave generator or source to emit acoustic shock waves and subjecting a vascular system containing red blood cells and surrounding muscle tissue peripherally through an extremity of a patient to the acoustic shock waves by stimulating the extremity wherein the extremity is positioned within a path of the emitted shock waves and away from a geometric focal volume or point of the emitted shock waves. The methods also treat muscle tissue of aging patients, from muscle regeneration or athletes for legal performance enhancement without drugs.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: July 19, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventor: John Warlick
  • Patent number: 11389371
    Abstract: A method of modulating glandular secretions by administering acoustic shock waves to a gland, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the gland to acoustic shock waves stimulating the gland to have a modulated response. The modulated response is one of an adjustment in hormonal release which increases low level output, decreases high level output or stabilizes erratic output. The emitted acoustic shock waves are focused or unfocused low energy acoustic shock waves. The gland underlies the patient's skin. The shock wave generator is acoustically coupled to the patient's skin using a coupling gel or liquid. The gland is one of a testicle, ovary, pituitary gland, adrenal gland, thyroid gland, thymus, pineal gland, parathyroid, or hypothalamus. The method can be repeated one or more times.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: July 19, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventor: John F. Warlick
  • Patent number: 11389373
    Abstract: The method of treating a patient addicted to pain medication or opioids has the step administering acoustic shock waves or pressure pulses to the patient. A second embodiment includes a treatment to reduce a patient's pain caused by a medical condition and/or medical procedure to reduce or eliminate the taking of addictive pain medication. The treatment has the step of administering acoustic shock waves or pressure pulses directed to an area near a source of the pain or to one or more reflexology zones or to one or more reflexology zones and to an area near the source of the pain or both to treat the medical condition or prior to the medical procedure or during the medical procedure or after the medical procedure or any combination thereof.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: July 19, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventors: John F. Warlick, John Patrick Finney
  • Patent number: 11311454
    Abstract: A handheld acoustic shock wave or pressure pulse applicator device has a body structure and an applicator head. The body structure has a proximal end and a distal end with a longitudinal axis extending between the ends. The applicator head is at the distal end. the head emits pressure pulses or shock waves at an inclined angle relative to the longitudinal axis of the body structure. The applicator head has a balloon or lens or membrane through which the emitted pressure pulses or shock waves pass. The lens or membrane is configured to be coupled directly or indirectly to an exposed soft tissue surface of a palate inside a patient's mouth to direct emitted pressure pulses or shock waves to the brain. The applicator device can be configured with the inclined obtuse angle fixed between 150 degrees and 90 degrees or can be adjustable between 180 degrees and 90 degrees.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: April 26, 2022
    Assignee: Softwave Tissue Regeneration Technologies, LLC
    Inventor: John F. Warlick
  • Patent number: 11096706
    Abstract: The present invention relates to a reflector for an acoustic shock or pressure wave head, wherein the reflector comprises an acoustically reflective surface formed by a body of rotation, said body of rotation being formed by rotation of an elliptical segment about a rotation axis which extends through a focal point of the ellipse and encloses an angle ? between 0.1° and 30° with the main axis of the ellipse.
    Type: Grant
    Filed: October 21, 2015
    Date of Patent: August 24, 2021
    Assignees: Medizinische Universität Innsbruck, Heart Regeneration Technologies GMBH
    Inventors: Christian Dorfmüller, Johannes Holfeld, Michael Grimm
  • Patent number: 9238044
    Abstract: The present invention relates to development of bioactive glass/glass-ceramic composition that are able to promote a fast deposition layer of carbonated hydroxyapatite upon immersion in simulated body fluid (SBF) for time periods as short as one hour. Such composition might include fluorides, and a variety of oxides (or their precursor compounds), such as Na2O—Ag2O—SrO—CaO—MgO—ZnO—P2O5—SiO2—Bi2O3—B2O3—CaF2, be prepared by the melt route or by the sol-gel process, with the specific composition and the preparation route selected according to the intended functionalities, which can present controlled biodegradation rate and bactericidal activity. The powders derived from glass melts purred in cold water (frits) may completely densify by sintering at temperatures up to 800° C. without devitrification, resulting in bioglass compacts with high flexural strength (˜85 MPa). The bioactive glass powders prepared by sol-gel densify at lower temperatures due to their higher specific surface area and reactivity.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: January 19, 2016
    Assignee: REG4LIFE REGENERATION TECHNOLOGY, S.A.
    Inventors: José Maria Da Fonte Ferreira, Ashutosh Goel
  • Publication number: 20140193499
    Abstract: The present invention relates to development of bioactive glass/glass-ceramic composition that are able to promote a fast deposition layer of carbonated hydroxyapatite upon immersion in simulated body fluid (SBF) for time periods as short as one hour. Such composition might include fluorides, and a variety of oxides (or their precursor compounds), such as Na2O—Ag2O—SrO—CaO—MgO—ZnO—P2O5—SiO2—Bi2O3—B2O3—CaF2, be prepared by the melt route or by the sol-gel process, with the specific composition and the preparation route selected according to the intended functionalities, which can present controlled biodegradation rate and bactericidal activity. The powders derived from glass melts purred in cold water (frits) may completely densify by sintering at temperatures up to 800° C. without devitrification, resulting in bioglass compacts with high flexural strength (˜85 MPa). The bioactive glass powders prepared by sol-gel densify at lower temperatures due to their higher specific surface area and reactivity.
    Type: Application
    Filed: April 5, 2012
    Publication date: July 10, 2014
    Applicant: REG4LIFE REGENERATION TECHNOLOGY, S.A.
    Inventors: José Maria Da Fonte Ferreira, Ashutosh Goel
  • Patent number: 8652503
    Abstract: A bone paste useful in the orthopedic arts, for example in the repair of non-union fractures, periodontal ridge augmentation, craniofacial surgery, implant fixation, impaction grafting, or any other procedure in which generation of new bone is deemed necessary, is provided by a composition comprising a substantially bioabsorbable osteogenic compound in a gelatin matrix. In various embodiments, the osteogenic compound is selected from (i) demineralized bone matrix (DBM); (ii) bioactive glass ceramic, BIOGLASS®, bioactive ceramic, calcium phosphate ceramic, hydroxyapatite, hydroxyapatite carbonate, corraline hydroxyapatite, calcined bone, tricalcium phosphate, or like material; (iii) bone morphogenetic protein, TGF-?, PDGF, or mixtures thereof, natural or recombinant; and (iv) mixtures of (i)-(iii).
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: February 18, 2014
    Assignees: University of Florida Research Foundation, Inc., Regeneration Technologies, Inc.
    Inventors: John F. Wironen, Jamie M. Grooms
  • Publication number: 20110091516
    Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.
    Type: Application
    Filed: September 9, 2010
    Publication date: April 21, 2011
    Applicant: Regeneration Technologies, Inc.
    Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell, JR.
  • Patent number: 7775995
    Abstract: The invention relates to a device for the generation of shock waves for medical therapy, having a shock source, an energy storage and a switch, wherein the energy storage is a capacitor with a high capacity.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: August 17, 2010
    Assignee: Tissue Regeneration Technologies LLC
    Inventor: Axel Voss